USPTO Can't Be Blamed For Patent On 'Fraud' Stem Cells

By Ryan Davis (February 19, 2014, 8:49 PM EST) -- The U.S. Patent and Trademark Office's decision to issue a human stem cell patent to a scientist found years ago to have fabricated his work may seem like sloppy work by the agency, but attorneys say the office doesn't have the ability to test the bona fides of an invention, nor does it need to in a system that renders fraudulent patents unenforceable....

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!